EXHIBIT 10.8
Agreement*
Party A: Drug clinical Study base under Harbin University of Medical Sciences
Party B: Harbin Three-Happiness Bioengineering Co., Ltd.
Grade One new Chinese Medicine, namely Cease Enuresis Soft Gel ,developed and
produced by Party B, is granted new medicine certificate and preproduction
approval Documentation Number. However, in terms of new provision of State Drug
Administration, new medicine is required to do IV phase clinical test to find
out if there is bad reaction, after new medicine goes into market. Party B is a
famous clinical base with advanced equipments and professional talents in China.
Both parties agree the following items after friendly discussion.
Item 1. Rights and obligations
1.1 Both parties design clinical test plan together, Party A is responsible to
do IV phase clinical test for Cease Enuresis Soft Gel, which are provided
by Party B.
1.2 Party B is responsible to promulgate and investigate bed-wetting towards 3
to 12 year-old children throughout Harbin City, it is expected to educate
over thirty thousand children to increase patients receiving retreating.
Item 2. Fees
500 patients together will be observed in this clinical test program. Party
B will supply scientific research cost to Party A at [Y]500 per patient. The
half of scientific research cost should be paid at the beginning of clinical
test, the rest part should be paid upon finishing clinical test report.
Item 3. Cooperation period: from June 20, 2003 to December 19, 2003
Item 4. Both parties agree to sign this agreement, each party keeps one copy of
executed agreement.
Chop of Drug clinical Study base under Harbin University of Medical Sciences
Chop of Harbin Three-Happiness Bioengineering Co., Ltd.
Date: June 20, 2003
*Translation from Chinese original
